{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01645293",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Uni-Koeln-1065"
      },
      "Organization": {
        "OrgFullName": "University of Cologne",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides",
      "OfficialTitle": "Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides",
      "Acronym": "TECLA"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2012",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StudyFirstSubmitDate": "July 11, 2012",
      "StudyFirstSubmitQCDate": "July 17, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 20, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "July 17, 2012",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 20, 2012",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Prof. Dr. med. Dr. rer. nat Cornelia Mauch",
        "ResponsiblePartyInvestigatorTitle": "Consultant dermatologist, CIO tumor centre",
        "ResponsiblePartyInvestigatorAffiliation": "University of Cologne"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Cologne",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Patients with cutaneous CD30 positive lymphoma will receive systemical and topical treatment with their own genetically modified T cells. Treatment evaluation consists of assessment of safety and preliminary evidence of response."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "CD30 Positive Cutaneous T Cell Lymphoma",
          "CD30 Positive Transformed Mycosis Fungoides"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "15",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Genetically modified T cells #1138",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Genetic: Genetically modified T cells # 1138"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Genetic",
            "InterventionName": "Genetically modified T cells # 1138",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Genetically modified T cells #1138"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Rate of patients experiencing dose limiting toxicities of engineered T cells #1138."
          },
          {
            "PrimaryOutcomeMeasure": "Definition of maximum tolerated dose (MTD) of engineered T cells #1138."
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Preliminary evidence of response to treatment",
            "SecondaryOutcomeDescription": "Complete Response (CR): Disappearance of treated lesion.\nPartial Response (PR): At least 30% decrease in the sum of two diameters compared to the initiatal diameters of the treated lesion.\nProgressive Disease (PD): At least 20% increase in the sum of two diameters of treated lesions.\nStable Disease (SD): Neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum of two diameters while on study."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSigned written informed consent, prior to pre-study screening and treatment, with the understanding that the consent may be withdrawn by the patient at any time without prejudice, ability to understand the written informed consent document.\nMale or female > 18 years of age to 70 years of age\nDiagnosis of primary cutaneous CD30+ large T cell lymphoma OR\nDiagnosis of transformed CD30+ mycosis fungoides, i.e.,\nHistological confirmation of diagnosis.\nmultiple (> 5) cutaneous tumor lesions (TNM EORTC 2007 T3, N1, clinical stage <IIb),\nMeasurable disease according to RECIST criteria\nRefractory or relapsed disease after at least one line of treatment, e.g. PUVA (Psoralen plus UVA), PUVA + Interferon, oral Bexarotene, low dose MTX)\nECOG performance status 0-3\nLife expectancy > 12 months\nFemale patients with childbearing potential must have a negative serum pregnancy test within two weeks of first dose of study drug. Male and female patients must agree to use an effective oral contraceptive method while on study treatment, if appropriate, and for a minimum of twelve months following study therapy\n\nExclusion Criteria:\n\nPreviously untreated patients\nPresence of any organ or brain involvement as determined during tumor staging by contrast computed tomography [CT] or magnetic resonance imaging [MRI] scan\nKnown hereditary blood coagulation disorders/DIC\nPrior allogeneic hematopoietic stem-cell or organ transplantation\nSevere cardiovascular disease like functionally restricting heart rhythm disturbance or heart malformation or severe hypertension, or cardiac insufficiency > NHYA-II\nknown active infection including HIV, Hepatitis B or C, VZV, or CMV\nInsufficient bone marrow reserve (Leucocytes <3.500/μl; Thrombocytes <100.000/μl)\nCreatinine-Clearance < 50 ml/min or Crea > 1.8 mg/dl\nBilirubin > 2 mg/dl; ASAT, ALAT > 2.5xN\nPregnancy (absence confirmed by serum/urine β-HCG) or breast-feeding\nKnown pulmonary dysfunction\nRequirement of chronic immune suppression\nTreatment with corticosteroids for concomitant or intercurrent disease\nHaving participated in another clinical trial or any IND in the preceding 4 weeks\nAnti-cancer chemotherapy in the preceding 4 weeks\nKnown drug abuse/alcohol abuse\nKnown allergic/hypersensitivity reaction to any of the components of the treatment\nKnown serious uncontrolled infections\nKnown active secondary malignancy or other previous malignancy within 5 years, with exception of a history of a previous basal cell carcinoma of the skin or pre-invasive carcinoma of the skin or cervix\nMedical or psychological condition or inadequate knowledge of german language which in the opinion of the investigator would not permit the patient to complete the study or meaningfully sign informed consent\nLegal incapacity or limited legal capacity",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Michael Hoffmann, MD",
            "CentralContactRole": "Contact",
            "CentralContactEMail": "michael.hoffmann@uk-koeln.de"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University Hospital of Cologne",
            "LocationCity": "Cologne",
            "LocationZip": "50937",
            "LocationCountry": "Germany",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Michael Hoffmann, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "michael.hoffmann@uk-koeln.de"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009181",
            "ConditionMeshTerm": "Mycoses"
          },
          {
            "ConditionMeshId": "D000008223",
            "ConditionMeshTerm": "Lymphoma"
          },
          {
            "ConditionMeshId": "D000016399",
            "ConditionMeshTerm": "Lymphoma, T-Cell"
          },
          {
            "ConditionMeshId": "D000009182",
            "ConditionMeshTerm": "Mycosis Fungoides"
          },
          {
            "ConditionMeshId": "D000016410",
            "ConditionMeshTerm": "Lymphoma, T-Cell, Cutaneous"
          },
          {
            "ConditionMeshId": "D000054446",
            "ConditionMeshTerm": "Lymphoma, Primary Cutaneous Anaplastic Large Cell"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000008232",
            "ConditionAncestorTerm": "Lymphoproliferative Disorders"
          },
          {
            "ConditionAncestorId": "D000008206",
            "ConditionAncestorTerm": "Lymphatic Diseases"
          },
          {
            "ConditionAncestorId": "D000007160",
            "ConditionAncestorTerm": "Immunoproliferative Disorders"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          },
          {
            "ConditionAncestorId": "D000008228",
            "ConditionAncestorTerm": "Lymphoma, Non-Hodgkin"
          },
          {
            "ConditionAncestorId": "D000001423",
            "ConditionAncestorTerm": "Bacterial Infections and Mycoses"
          },
          {
            "ConditionAncestorId": "D000007239",
            "ConditionAncestorTerm": "Infections"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10372",
            "ConditionBrowseLeafName": "Lymphoma",
            "ConditionBrowseLeafAsFound": "Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M17981",
            "ConditionBrowseLeafName": "Lymphoma, T-Cell",
            "ConditionBrowseLeafAsFound": "T-cell Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M17984",
            "ConditionBrowseLeafName": "Lymphoma, T-Cell, Cutaneous",
            "ConditionBrowseLeafAsFound": "Cutaneous T-Cell Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11288",
            "ConditionBrowseLeafName": "Mycoses",
            "ConditionBrowseLeafAsFound": "Mycosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11289",
            "ConditionBrowseLeafName": "Mycosis Fungoides",
            "ConditionBrowseLeafAsFound": "Mycosis Fungoides",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M26869",
            "ConditionBrowseLeafName": "Lymphoma, Primary Cutaneous Anaplastic Large Cell",
            "ConditionBrowseLeafAsFound": "Primary Cutaneous CD30+ Large T Cell Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10377",
            "ConditionBrowseLeafName": "Lymphoproliferative Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10355",
            "ConditionBrowseLeafName": "Lymphatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9358",
            "ConditionBrowseLeafName": "Immunoproliferative Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10374",
            "ConditionBrowseLeafName": "Lymphoma, Non-Hodgkin",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9435",
            "ConditionBrowseLeafName": "Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5520",
            "ConditionBrowseLeafName": "Communicable Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3874",
            "ConditionBrowseLeafName": "Bacterial Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3873",
            "ConditionBrowseLeafName": "Bacterial Infections and Mycoses",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T3543",
            "ConditionBrowseLeafName": "Lymphosarcoma",
            "ConditionBrowseLeafAsFound": "Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T1689",
            "ConditionBrowseLeafName": "Cutaneous T-cell Lymphoma",
            "ConditionBrowseLeafAsFound": "Cutaneous T-Cell Lymphoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T3986",
            "ConditionBrowseLeafName": "Mycosis Fungoides",
            "ConditionBrowseLeafAsFound": "Mycosis Fungoides",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC15",
            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}